Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: Hope who wrote (511)	1/20/1999 4:05:00 PM
From: Ordus	Read Replies (2) \| Respond to of 1084

ASTM not mentioned specifically in the Jan 15th news. DayInvestor was watching this almost as closesly as the experts, who got on the boat yesterday. People buy what they know, right now the discoveries in biotech and specifically, Aastrom's work, have not been sufficiently introduced to the public. Once people stop clamoring for overpriced internut and tech stocks they'll realize the potential here. It'll take a flurry of press releases from a number of biotech firms to draw the media's attention, then the sector, and ASTM, will benefit. The PR should start flying in early Feb with that upcoming conference, look forward to some striking revelations of just how far we are coming. Then again maybe the whole sector will bomb amid a flurry of regulation and I'll lose my shirt. Only time will tell and until then it's just fun to think about it.